Guardian Pharmacy Services, Inc.’s Lock-Up Period Set To End on March 25th (NYSE:GRDN)

Guardian Pharmacy Services’ (NYSE:GRDN) lock-up period is set to expire on Tuesday, March 25th. Guardian Pharmacy Services had issued 8,000,000 shares in its IPO on September 26th. The total size of the offering was $112,000,000 based on an initial share price of $14.00. After the end of Guardian Pharmacy Services’ lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Guardian Pharmacy Services Stock Performance

NYSE GRDN opened at $20.48 on Tuesday. Guardian Pharmacy Services has a 1-year low of $14.16 and a 1-year high of $25.74. The firm’s 50 day moving average is $20.42.

Institutional Trading of Guardian Pharmacy Services

A number of large investors have recently bought and sold shares of GRDN. R Squared Ltd bought a new position in shares of Guardian Pharmacy Services in the fourth quarter valued at approximately $30,000. Investment Research & Advisory Group Inc. bought a new position in Guardian Pharmacy Services in the 4th quarter valued at $34,000. BNP Paribas Financial Markets acquired a new position in Guardian Pharmacy Services in the fourth quarter worth $37,000. Compass Financial Services Inc bought a new stake in shares of Guardian Pharmacy Services during the fourth quarter worth $58,000. Finally, JPMorgan Chase & Co. acquired a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at $77,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.